Letter: Post‐ COVID ‐19 functional dyspepsia and irritable bowel syndrome—Authors' reply
Alimentary Pharmacology & Therapeutics · 2023
DOI: 10.1111/apt.17554 ↗At a glance
Leserbrief in Alimentary Pharmacology & Therapeutics, 2023. Written by Giovanni Marasco and 5 co-authors. Institution: IRCCS Azienda Ospedaliero Universitaria di Bologna, Bologna, Italy. Major MEDLINE topics: Dyspepsia, Irritable Bowel Syndrome, COVID-19, Gastritis. 10 references. Funded by: Fondazione Cassa di Risparmio in Bologna, Fondazione del Monte di Bologna e Ravenna, Horizon 2020 Framework Programme.
Abstract (original language)
LINKED CONTENT This article is linked to Marasco et al papers. To view these articles, visit https://doi.org/10.1111/apt.17513 and https://doi.org/10.1111/apt.17539
Subjects
MeSH terms (MEDLINE)
Authors and institutions
- IRCCS Azienda Ospedaliero Universitaria di Bologna, Bologna, Italy.
- Department of Medical and Surgical Science, University of Bologna, Bologna, Italy.
- Gastroenterology and Endoscopy Unit, S. Elia-Raimondi Hospital, Caltanissetta, Italy.
ORCID profiles: Giovanni Marasco, Marcello Maida, Cesare Cremon, Maria Raffaella Barbaro, Giovanni Barbara
Funding
- Fondazione Cassa di Risparmio in Bologna
- Fondazione del Monte di Bologna e Ravenna
- Horizon 2020 Framework Programme
- Ministero della Salute
Cite
APA
Marasco, G., Maida, M., Cremon, C., Barbaro, M. R., Stanghellini, V., & Barbara, G. (2023). Letter: Post‐ COVID ‐19 functional dyspepsia and irritable bowel syndrome—Authors' reply. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.17554
Vancouver
Marasco G, Maida M, Cremon C, Barbaro MR, Stanghellini V, Barbara G. Letter: Post‐ COVID ‐19 functional dyspepsia and irritable bowel syndrome—Authors' reply. Alimentary Pharmacology & Therapeutics. 2023. doi:10.1111/apt.17554
BibTeX
@article{Marasco2023,
author = {Marasco, Giovanni and Maida, Marcello and Cremon, Cesare and Barbaro, Maria Raffaella and Stanghellini, Vincenzo and Barbara, Giovanni},
title = {Letter: Post‐ COVID ‐19 functional dyspepsia and irritable bowel syndrome—Authors' reply},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2023},
doi = {10.1111/apt.17554}
}
EUVIMED